Evidence that myocardial Na/I symporter gene imaging does not perturb cardiac function

Journal of Nuclear Medicine

Volumn 47, Issue 11, 2006, Pages 1851-1857

  Lee, Kyung Han ^a,c   Bae, Jun Sang ^a   Lee, Sang Chul ^a   Paik, Jin Young ^a   Matsui, Takashi ^b   Jung, Kyung Ho ^a   Ko, Bong Ho ^a   Kim, Byung Tae ^a  

^a Sungkyunkwan University   (South Korea)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Samsung Medical Center   (South Korea)

Author keywords

Gene therapy; Myocardium; Radioiodide; Reporter gene; Scintigraphy

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADENOVIRUS VECTOR; CREATINE KINASE; ENHANCED GREEN FLUORESCENT PROTEIN; MYELOPEROXIDASE; SODIUM IODIDE I 123; SODIUM IODIDE SYMPORTER; COTRANSPORTER; GREEN FLUORESCENT PROTEIN; RADIOACTIVE IODINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EMBRYO; ENZYME ANALYSIS; ENZYME ASSAY; GENE; GENE EXPRESSION; GENE TRANSFER; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART MUSCLE CELL; HEART RATE; HISTOLOGY; IMAGING; INFLAMMATION; ISCHEMIA; MEDIASTINUM; MICROSCOPY; MYOBLAST; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SCINTIGRAPHY; SODIUM IODIDE SYMPORTER GENE; ADENOVIRUS; ANIMAL; CELL SURVIVAL; GENE THERAPY; HUMAN; METABOLISM; METHODOLOGY; PATHOLOGY; REPORTER GENE; SCINTISCANNING; SPRAGUE DAWLEY RAT;

ADENOVIRIDAE; ANIMALS; CELL SURVIVAL; CREATINE KINASE; ECHOCARDIOGRAPHY; GENE THERAPY; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; IODINE RADIOISOTOPES; MYOCARDIUM; RADIONUCLIDE IMAGING; RATS; RATS, SPRAGUE-DAWLEY; SYMPORTERS;

EID: 35148887256     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Isner JM. Myocardial gene therapy. Nature. 2002;415:234-239.
2. Kizana E, Alexander IE. Cardiac gene therapy: therapeutic potential and current progress. Curr Gene Ther. 2003;3:418-451.
3. Williams ML, Koch WJ. Viral-based myocardial gene therapy approaches to alter cardiac function. Annu Rev Physiol. 2004;66:49-75.
4. Guzman RJ, Lemarchand P, Crystal RG, Epstein SE, Finkel T. Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res. 1993;73:1202-1207.
5. Barr E, Kalynych AM, Tripathy SK, Kozarsky K, Wilson JM, Leiden JM. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther. 1994;1:51-58.
6. Leor J, Quiñones MJ, Patterson M, Kedes L, Kloner RA. Adenovirus-mediated gene transfer into infarcted myocardium: feasibility, timing, location of expression. J Mol Cell Cardiol. 1996;28:2057-2067.
7. Wu JC, Tseng JR, Gambhir SS. Molecular imaging of cardiovascular gene products. J Nucl Cardiol. 2004;11:491-505.
8. Avril N, Bengel FM. Defining the success of cardiac gene therapy: how can nuclear imaging contribute? Eur J Nucl Med Mol Imaging. 2003;30:757-771.
9. Wu JC, Yla-Herttuala S. Human gene therapy and imaging: cardiology. Eur J Nucl Med Mol Imaging. 2005;32(suppl):S346-S357.
10. Inubushi M, Wu JC, Gambhir SS, et al. Positron-emission tomography reporter gene expression imaging in rat myocardium. Circulation. 2003;107:326-332.
11. Lee KH, Kim HK, Paik JY, et al. Accuracy of myocardial sodium/iodide symporter gene expression imaging with radioiodide: evaluation with a dualgene adenovirus vector. J Nucl Med. 2005;46:652-657.
12. Miyagawa M, Beyer M, Wagner B, et al. Cardiac reporter gene imaging using the human sodium/iodide symporter gene. Cardiovasc Res. 2005;65:195-202.
13. Miyagawa M, Anton M, Wagner B, et al. Non-invasive imaging of cardiac transgene expression with PET: comparison of the human sodium/iodide symporter gene and HSV1-tk as the reporter gene. Eur J Nucl Med Mol Imaging. 2005;32:1108-1114.
14. +/I symporter (NIS): imaging and therapeutic applications. Semin Nucl Med. 2004;34:23-31.
15. Cho JY. A transporter gene (sodium iodide symporter) for dual purposes in gene therapy: imaging and therapy. Curr Gene Ther. 2002;2:393-402.
16. Chung JK. Sodium iodide symporter: its role in nuclear medicine. J Nucl Med. 2002;43:1188-1200.
17. Groot-Wassink T, Aboagye EO, Glaser M, et al. Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene. Hum Gene Ther. 2002;13:1723-1735.
18. Boland A, Ricard M, Opolon P, et al. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res. 2000;60:3484-3492.
19. Haberkorn U, Kinscherf R, Kissel M, et al. Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose. Gene Ther. 2003;10:774-780.
20. Ménard C, Pupier S, Mornet D, Kitzmann M, Nargeot J, Lory P. Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells. J Biol Chem. 1999;274:29063-29070.
21. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-367.
22. Watson LE, Sheth M, Denyer RF, Dostal DE. Baseline echocardiographic values for adult male rats. J Am Soc Echocardiogr. 2004;17:161-167.
23. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods. 1985;14:157-167.
24. French BA, Mazur W, Geske RS, Bolli R. Direct in vivo gene transfer into porcine myocardium using replication deficient adenoviral vectors. Circulation. 1994;90:2414-2424.
25. Gilgenkrantz H, Duboc D, Juillard V, et al. Transient expression of genes transferred in vivo into the heart using first generation adenoviral vectors: role of the immune response. Hum Gene Ther. 1995;6:1265-1274.
26. - symport in rat cardiac myocytes. Physiology. 1998;512:137-148.
27. - symporter: mechanism, stoichiometry, and specificity. J Biol Chem. 1997;272:27230-27238.
28. - symporter. Biochem Biophys Res Commun. 1997;231:731-734.
29. Kafri T, Morgan D, Kral T, Sarvetnick N, Sherman L, Verma I. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. Proc Natl Acad Sci U S A. 1998;95:11377-11382.
30. Stripecke R, Carmen Villacres M, Skelton D, Satake N, Halene S, Kohn D. Immune response to green fluorescent protein: implications for gene therapy. Gene Ther. 1999;6:1305-1312.
31. Brennan ML, Hazen SL. Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment. Curr Opin Lipidol. 2003;14:353-359.
32. Patel SR, Lee LY, Mack CA, et al. Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121. Hum Gene Ther. 1999;10:1331-1348.
33. Magovern CJ, Mack CA, Zhang J, et al. Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector. Ann Thorac Surg. 1996;62:425-433.
34. Li JJ, Ueno H, Pan Y, et al. Percutaneous transluminal gene transfer into canine myocardium in vivo by replication-defective adenovirus. Cardiovasc Res. 1995;30:97-105.